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Neuropeptide YHoodia gordonii (family: Apocynaceae) is used traditionally by the Khoi-San tribes to control hunger. It has
become extremely popular and has triggered commercial interest due to its appetite suppressant property.
The present study was undertaken to investigate the appetite regulatory mechanism and associated metabol-
ic changes induced by the herb. Effect of organic solvent extract of H. gordonii on food intake and body weight
of male Sprague Dawley rats was monitored at three different doses 50, 100 and 150 mg/kg body weight,
given orally for ﬁve days. Subsequently, the dose of 100 mg/kg body weight was selected for further studies
on the regulatory hormones and biochemical variables. Dose-dependent reduction in food intake (12–26%)
was observed at a dose of 100 and 150 mg/kg body weight (pb0.05). Appetite suppression persisted for
6 h and food intake was restored within 24 h after stopping of the treatment. There was an increase in
liver glycogen stores, activity of mitochondrial CPT-1 and thyroid hormones in treated animals. The circulat-
ing levels of NPY and IGF-1 were decreased with marginal increase in leptin and CCK, in case of treated rats.
There was no change in blood glucose and insulin levels were not affected signiﬁcantly. The hormonal and
metabolic changes due to treatment with the H. gordonii extract may be responsible for its anorectic activity.
© 2013 SAAB. Published by Elsevier B.V. All rights reserved.1. Introduction
There has been a global increase in the use of herbal products for
health care (Hermann and von Richter, 2012). Traditional systems
of medicine rely on herbs for their medicinal properties (Arun and
Nalini, 2002; Caili et al., 2006). Hoodia gordonii, is a popular supple-
ment and one of the most widely consumed appetite suppressant of
natural origin. It is a succulent plant that belongs to the family
Apocynaceae and grows throughout South Africa and Namibia
(Brunys, 2005). Hoodia with the name ‘Xhoba’ have been in use by
the indigenous Khoi-San tribes of the Kalahari during their long hunt-
ing trips to curb hunger or during periods of famine. Further investi-
gation by the Council for Scientiﬁc and Industrial Research (CSIR,
South Africa) about the genus Hoodia led to the ﬁnding that out of
the 13 reported species only H. gordonii and H. pilifera exert anorectic
activity (Avula et al., 2006). Initial studies demonstrated a decrease in
food intake and body weight in obese and lean rats (Tulp et al., 2001,
2002). It is reported that H. gordonii is a rich source of pregnane,
oxypregnane and steroidal glycosides (Shukla et al., 2009). Experi-
ments performed by MacLean and Luo (2004) demonstrated that a
speciﬁc steroidal glycoside, P57 when administered by i.c.v injection
increases the amount of ATP in the hypothalamus, which stimulates
satiety and is indicative of a central mechanism of action. However,
a pharmacokinetic study revealed that oral administration of Hoodiaingh).
by Elsevier B.V. All rights reservedextract, does not cause an increase in P57 in brain (Madgula et al.,
2010). The precise mechanism of its action has not been elucidated.
Limited human clinical trials with H. gordonii have been done. An ob-
servational pilot research study was performed on obese participants
and effects on body weight and appetite were assessed (Holt and
Taylor, 2006). A speciﬁc product called Hoodia Supreme was admin-
istered twice daily in form of capsule that contained 400 mg of pure
H. gordonii per capsule. Reduction in appetite (500–1000 calories
per day) and weight loss (2–15 lb) were reported in all subjects
over the duration of 4 weeks (Holt and Taylor, 2006). In a double
blind, placebo controlled study, a group of obese free- feeding volun-
teers were treated with H. gordonii. A reduction of food intake up to
1000 calories per day (approx.) and body weight loss of about 2 kg
along with decrease in blood glucose and triglycerides was observed
(Glasl, 2009; Holt and Taylor, 2006).
A puriﬁed solvent extract, HgPE (H. gordonii puriﬁed extract)
containing 79.3% w/w steroid glycosides was formulated as a ﬂavoured
yoghurt drink (Blom et al., 2011). This HgPE caused a signiﬁcant dose
dependent reduction in food intake and body weight of rats when re-
peatedly administered for 13 weeks (Blom et al., 2011). This HgPE ex-
tract was also evaluated on healthy overweight women at dose of
1110 mg HgPE twice/day, 1 h before breakfast and dinner for a period
of 15 days. The placebo group was given a yoghurt drink. The mean
effects on ad libitum energy intakes and body weights did not differ
signiﬁcantly between the treated and placebo groups. Inspite of the
enormous commercial interest in H. gordonii supplements, there is in-
sufﬁcient published scientiﬁc data on regulation of appetite. Some.
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Hoodia species but there are no reports on its effect on the appetite
regulatory peptides. Based on this, the study was undertaken to further
investigate the acclaimed anorectic activity of H. gordonii, its possible
effects on energy metabolism and other biochemical changes using
young adult Sprague Dawley rats as an experimental model.
2. Materials and methods
2.1. Plant material
Authenticated dry powder of (cultivated) H. gordonii was a gift
from M/S Farm Vredelus PTY LTD, Farm Douglas, Namibia. Certiﬁcate
of Analysis along with the LCMS chromatogram for H. gordonii were
also provided by them (LC/MS analysis was done at University of
Stellenbosch, South Africa).
2.1.1. Preparation of extract
Organic solvent extract was prepared using a mixture of
dichloromethane-methanol (1:1) (Corley and Miller, 2009). Dry
powder was weighed (20 g) and mixed with a 100 ml solvent mix-
ture and kept overnight for extraction. The organic layer was sepa-
rated from raw plant material by centrifugation at 3000 ×g for
15 min at room temperature. Extraction was repeated twice under
identical conditions, supernatants were combined and dried at
40 °C. The yield of the extract was 8.0% of the dry powder supplied
by the manufacturer.
2.2. Animals, treatment, monitoring of food intake and body weight
Male Sprague Dawley rats, weighing 200–250 g, bred and reared in
the Experimental Animal Facility of the Institute were used in the
study. Animals were maintained at a temperature of 22°±1 °C and a
humidity of 55–60% in light-controlled room (lights on at 6:30 h, lights
off at 18:30 h). Rats were habituated to a restricted day-time feeding
regimen two weeks prior to the experimentation by providing them
food only for 6 h during the light phase for monitoring of food intake.
Rats were provided commercial rodent diet supplied by M/S Golden
feed Pvt Ltd., Delhi and water ad libitum. All procedures and protocols
used in the present study were approved by the Animal Care and Use
Committee of the Institute and followed the guidelines documented
in the National Institute of Health's Guide for the Care and Use
of Laboratory Animals. The animals were randomly divided into
control and experimental groups prior to the beginning of the
experiments.
Initially six groups of animals (n=6 in each) were treated with
crude alcoholic extract at doses of 50, 100 and 150 mg/kg body
weight orally using a rodent feeding needle once daily for ﬁve days.
The respective control groups for each treatment group received
equal volume of tap water using a rodent feeding needle. The extract
was given in the morning every day for ﬁve days, at the time of pro-
viding food and water to the animals. The minimum effective dose of
100 mg/kg body weight was selected subsequently for further bio-
chemical experiments. Food was weighed on a digital balance every
2 h i.e. at 2 h, 4 h and 6 h to see if the extract has a continuous or pro-
gressive anorectic action. Food intake was monitored additionally for
three days (over an eight day period) to ﬁnd out any residual effect
after stopping the treatment. This was performed on a separate
batch of rats comprising of two groups, control and treated (n=6 in
each). Changes in body weight were monitored daily post treatment.
2.3. Sample collection for biochemical analysis
After completion of the ﬁve day treatment, rats were fasted
overnight, anaesthetized and sacriﬁced. Blood plasma was collected
by centrifugation at 1000 ×g for 10 min at 4 °C. The weight of theorgans — liver, spleen, kidney, brain was recorded along with gastroc-
nemius muscle and epididymal fat tissue. For glycogen estimation the
weighed portions of liver were dissolved in 30% KOH immediately
after removal, precipitated with 95% ethanol in the presence of sodium
sulphate. Ten percent liver and brain homogenates (w/v) were pre-
pared in 150 mmKCl using Polytronhomogeniser andwere centrifuged
at 3000 ×g for 15 min at 4 °C. The supernatants were divided into ali-
quots and frozen at−80 °C until assayed. Livermitochondriawere sep-
arated by differential centrifugation at 12,000 ×g for 30 min at 4 °C and
stored at−80 °C for CPT-1 activity analysis.
In a separate experiment to study the effect on blood glucose levels,
samples were collected from the retro-orbital plexus at 1 h, 2 h and 4 h
after giving an oral dose of 100 mg/kg body weight (n=6).
2.4. Biochemical estimations
Bloodglucosewasmeasuredusing glucose oxidase–peroxidasemeth-
od. Tissue glycogen was estimated using the method of Montgomery
(1957). CPT-1 (Carnitine Palmitoyl Transferase-1) activity was assayed
using the method of Halperin and Pande (1979). Mitochondrial
protein content was measured by the method of Lowry et al. (1951).
Na+/K+ATPase activity was measured in the brain homogenate using
the method of Esmann (1988). Radio immunologic assay (RIA) kits
from Phoenix Pharmaceuticals, Burlingame, CA were used for detection
of plasma ghrelin, neuropeptide Y (NPY) and cholecystokinin (CCK)
levels. Plasma leptin and adiponectin concentrations were measured
with a commercially available rat ELISA kit from Ray Biotech, Inc., USA.
Plasma insulin concentrations were determined using a direct ELISA kit
bought fromMercodia, Uppsala, Sweden. Plasma sampleswere extracted
using ethyl ether for corticosterone estimation and estimated using an
ELISA kit (Neogen Corporation, USA). Plasma levels of insulin-like growth
factor 1 (IGF-1) were analyzed with an EIA kit fromMediagnost, Germa-
ny. AMP kinase activity, levels of tri-iodothyronine (T3), thyroxine (T4)
and 5-Hydroxytryptamine (5-HT) in brain homogenates and plasma
were measured using kit from Cusabio biotech Co., Ltd.
2.5. Statistical analysis
All the data are presented as mean±SD and statistically analyzed
using unpaired Student's t-test. The p valueb0. 05 was considered
signiﬁcant change.
3. Results and discussion
3.1. Effect on food intake, body weight and organ weights
H. gordonii crude extract at oral dose of 100 mg/kg and 150 mg/kg
produced a dose-dependent decrease in food intake over the 6 h period
on all the ﬁve days. There was no change in food intake at a lower dose
of 50 mg/kg body weight (Table 1). There was a decrease in food intake
by 17.5% (12.4%–22.3%) and 22.8% (18.4%–26.7%) respectively at dosage
of 100 and 150 mg/kg body weight (pb0.05) (Table 1). In the experi-
ment carried out tomonitor food intake at different time points a reduc-
tion in food intake by 15%was observed at 2 h following administration
and remained up to the sixth hour (Fig. 1a). The food intake returned to
the levels of untreated group from day 6 to day 8 after the 100 mg/kg
body weight dose was discontinued on day 5 (Fig. 1b). This indicates
that the extract has a transient action and not a sustained effect. The
body weight was not affected in the treated animals (3.8%) compared
to control (3.6%) at the dose of 50 mg/kg bodyweight (Fig. 1c). Similar-
ly, at dose of 100 mg/kg body weight there was no signiﬁcant effect on
body weight in treated animals (3.7%) compared to control (4%)
(Fig. 1d). At 150 mg the rate of body weight gain in treated rats was
1.8% as compared to 6% in control indicating a reduction in weight
gain due to treatment (Fig. 1e). No signiﬁcant differences in theweights
Table 1




Day 1 Day 2 Day 3 Day 4 Day 5 Mean±SD
50 C (g) 96.0 100.0 95.0 96.0 99.0 97.2±2.4
T (g) 97.0 101.0 94.9 96.0 100.0 97.7±2
Diff (g) +1 +1 −0.1 0 +1 0.5±0.6
Diff (%) 1.04 1 2.7 0 1
100 C (g) 97 101 100 95 97 98.0±2.4
T (g) 85 84 81.3 78.5 75.4 80.8±4.0
Diff (g) −12 −17 −18.7 −16.5 −21.6 17.2±3.5*
Diff (%) 12.4 16.8 18.7 17.4 22.3
150 C (g) 97 99 95 95.5 97.6 97.8±1.4
T (g) 74.5 78 77.5 72 71.5 74.7±2.7
Diff (g) −22.5 −21 −17.5 −23.5 −26.1 22.1±2.8*
Diff (%) 23.2 21.2 18.4 24.6 26.7
Values are mean±SD (n=6), C: Control, T: Treated, *pb0.05; + denotes an increase
and − denotes a decrease in food intake in comparison to control.
Fig. 1. (a) Effect of H. gordonii treatment on food intake at speciﬁc time points for 6 h at dose 1
100 mg/kg body weight (n=6), combined food intake of 6 rats. (c) Changes in body weigh
(d) Changes in bodyweight of rats followingH. gordonii administration at dose of 100 mg/kg bo
at dose of 150 mg/kg body weight (n=6).
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groups (data not shown).
The decrease in food intake and reduction in weight gain in the treat-
ed groups in the present study indicates appetite suppression in rats and
this observation is similar to earlier reports (van Heerden et al., 2007;
MacLean and Luo, 2004; Tulp et al., 2001). However, the form of the
herb used i.e. pure glycoside or a formulated product, the dosage and
the extent towhich food consumptionwas suppressed varied. The recov-
ery in food intake after stopping the treatment is also reported in an ear-
lier study by van Heerden et al. (2007). Holt (2005) quotes H. gordonii is
not a ‘magic bullet’ for overweight problems but imperatively modiﬁes
food behavior and thereby leads to the controlled energy intake.
Human trial with H. gordonii showed reductions in food intake and
body weight from baseline but with no signiﬁcant difference between
the experimental and placebo groups (Blom et al., 2011). This could be
due to the complex interactions between the biological mechanisms of
appetite and environmental challenges that determine drive to eat.00 mg/kg body weight (n=6). (b) Recovery in food intake after stopping treatment with
t of rats following H. gordonii administration at dose of 50 mg/kg body weight (n=6).
dyweight (n=6). (e) Changes in bodyweight of rats followingH. gordonii administration
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The blood glucose levels were not affected by treatment at 1 h, 2 h
and 4 h post intervention (Fig. 2). However, there was a signiﬁcant
increase (pb0.01) in the hepatic glycogen content (control: 0.46±
0.75 mg/g wet tissue, HG: 1.77±0.72 mg/g wet tissue). Although
the herb is postulated to alter appetite through the CNS, it may also
have a peripheral action (MacLean and Luo, 2004). The increase in
liver glycogen is probably related to a change in sugar metabolism
through the glycosides present in Hoodia (Holt, 2006). The blood glu-
cose concentration signals the induction of hunger sensation in rats
(Poothullil, 1992). It has been suggested that the effects of Hoodia
on blood glucose and insulin are not direct, and may occur only
when on a calorie reduced diet or in combination with cinnamon
and anti-hyperglycaemic compounds to treat Syndrome X (Holt,
2006). Increased glycogen production leads to an early feeling of full-
ness. This is achieved by stimulating the glucoreceptors that sends sa-
tiety signals to the brain via the vagus nerve (Anderson, 1994).3.3. Effect on enzyme activities
The gastrointestinal tract and the adipose tissue both send signals
to the brain and regulate the energy homeostasis (Stanley et al.,
2005). Since the steroidal glycoside, P57 present in H. gordonii resem-
bles the structure of cardiac glycosides (MacLean and Luo, 2004;
Tucci, 2010) the activity of Na+/K+ATPase was measured in whole
brain and no change was observed (control: 0.018±0.01 mmol/mg
protein/min, HG: 0.019±0.02 mmol/mg protein/min). CPT-1 activity
in the isolated liver mitochondria was found to be signiﬁcantly in-
creased in the treated group (control: 10.81±4.50 μmol/min/mg
protein, HG: 16.73±6.54 μmol/min/mg protein, pb0.05) while the
AMPK activity measured in crude liver homogenates was not changed
with HG supplementation (control: 314±54 pg/mg protein, HG:
292.97±9.18 pg/mg protein, pb0.05). The signiﬁcantly increased ac-
tivity of CPT-1, an enzyme of the fatty acid oxidation, may be in part
attributed to the raised adiponectin in the present study, this may af-
fect lipid metabolism and enhances fatty acid oxidation (Xu et al.,
2003). However, it appears that adiponectin did not exert its effect
peripherally to stimulate the liver AMP kinase activity, thereby not in-
creasing food intake (Kubota et al., 2007). Depleting Adenosine tri-
phosphate (ATP) or increasing Adenosine monophosphate (AMP)
levels activates AMPK (Shetty et al., 2009). This reinforces the obser-
vation, as a no signiﬁcant change in the AMPK activity could be due toFig. 2. Effect on blood glucose levelsmeasured at 1 h, 2 h and 4 h afterH. gordonii supple-
mentation at 100 mg/kg body weight (n=6), no food restriction during the experiment
was done.no ATP depletion resulting in a feeling of satiety (MacLean and Luo,
2004).
3.4. Effect on appetite regulatory peptides
Plant extracts usually target several systems of the body as majority
of them are not single compounds but a mixture of different molecules.
Also, since some cellular receptors tend to be widely distributed, a sin-
gle molecule can have several metabolic effects (Tucci, 2010). Food in-
take and the appetite hormone systems like leptin, ghrelin and IGF-1
closely affect the nutritional status.
Insulin regulates glucose homeostasis by increasing glucose up-
take, and the fall of blood glucose is a stimulus for increased appetite.
The insulin levels did not show any signiﬁcant change in the present
study. Insulin is known to increase the production of IGF-1 (Butler
and LeRoith, 2001). Low IGF-1 levels are seen in fasting and are in-
creased in response to high calorie intakes (Sridhar and Goodwin,
2009). The decline in the plasma IGF-1 levels (pb0.05) in the present
study may be in response to the lower calorie intake.
A decline in ghrelin levels has an appetite lowering effect while lep-
tin decline has appetite stimulating effects. In the present study an in-
crease in leptin and concomitant suppression in ghrelin levels, though
values were statistically not signiﬁcant. Plasma ghrelin concentrations
are known to correlate with calories ingested (Cummings et al., 2001).
The NPY/AgRP neurons play an important role as they mediate the ef-
fect of ghrelin (Cowley et al., 2003) and since leptin receptors are pres-
ent on these neurons, leptin inhibits NPY (Baskin et al., 1999). The
signiﬁcant decrease in plasma NPY (pb0.05) and leptin levels show a
similar association in the present study. Apart from neuropeptides,
the role of monoamines in eating has also been observed. The 5-HT is
a suggestive satiety agent (Fernstrom and Fernstrom, 2001). No signif-
icant effect of H. gordonii on serotonin levels were observed. Therefore
possibility of serotonin reuptake inhibition remains unidentiﬁed and
needs further study. Both serotonin and corticosterone in rodents
have the highest peak during the active period of the diurnal cycle. In
the present study circulating levels of corticosterone, those of the light
period,were found to be signiﬁcantly decreased (pb0.05) in the treated
group. Glucocorticoids stimulate food intake by promoting NPY func-
tions (Woods et al., 2004). A decline in both of these peptides in this
study may also have a role in appetite suppression. A marginal increase
in CCK secretionwas also noted. CCK is known to be a peripheral gastro-
intestinal satiety signal. Recent research has proposed that the bitter
taste of H. gordoniimay lead to secretion of CCK and inﬂuence appetite
control (Le Nevé et al., 2010). Additionally the appetite and metabolic
rate are controlled through the peripheral effects of thyroid hormone
that have clinical signiﬁcance on energy intake. These effects were
thought to be peripheral, but only recently it's been known to act cen-
trally as well (Amin et al., 2011). T3 and T4 displayed a signiﬁcant rise
(pb0.05) after the supplementation. This could lead to an assumption
of elevated basal energy expenditure arising from increased fuelmetab-
olism (Pucci et al., 2000). It could have a role in lipolysis, though its
function in lipid regulation is complicated (Mariash, 2003). Besides,
thyroid hormones promotes carbohydrate metabolism and maintains
glucose homeostasis (Chidakel et al., 2005). The levels of glucose and
glycogen in the treated group may be mediated to a certain extent by
the increased thyroid hormones (Table 2).
In the present study changes in levels of appetite regulatory pep-
tides in response toH. gordonii supplementation in vivomay be respon-
sible for decreased food intake. However, it is difﬁcult to pin point any
onemolecule responsible for the action as appetite regulation is a com-
plex phenomenon and plant extract usedmay have several compounds
other than P57. The short term administration of the crude extract gen-
erates adequate evidence of it being an appetite suppressant. This im-
plies that if given for a longer period it may exert a pronounced effect.
Traditional belief that herbs are safer than synthetic compounds is one
of the classical arguments, which is yet to be proven. The extensive
Table 2
Effect of crude H. gordonii extract supplementation (100 mg/kg body weight) for ﬁve
days on different hormones in plasma.
Appetite regulatory peptides Experimental groups
Control Treated
Insulin (ng/ml) 0.36±0.05 0.30±0.03
Insulin-like growth factor 1 (ng/ml) 477.50±136.50 371.29±140.12*
Leptin (pg/ml) 839.59±395.16 956.01±549.86
Ghrelin (pg/ml) 1204.58±141.06 1159.00±53.63
CCK (pg/ml) 281.18±16.93 307.83±18.22
Adiponectin (ng/ml) 82.40±56.98 101.81±87.77
Brain serotonin (ng/ml) 1.19±0.14 1.09±0.29
Plasma serotonin (ng/ml) 64.62±26.30 78.10±31.16
Corticosterone (ng/ml) 67.67±11.23 56.70±12.38*
Neuropeptide Y (pg/ml) 1124.41±535.31 605.41±397.81*
Tri-iodothyronine (ng/ml) 0.94±0.16 1.47±0.23*
Thyroxine (ng/ml) 35.75±3.75 40.08±2.57*
Expressed as mean±SD (n=6), *pb0.05 in comparison with control.
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main undetermined. Present investigation on experimental animals
needs further studies on humans since the feedingbehaviour of humans
and rodents are different.
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